Celerion

Celerion is a prominent Clinical Research Organization (CRO) that specializes in early phase drug development services, working diligently to support pharmaceutical companies in expediting their products to market. Established in 2010, Celerion has since earned its reputation as a leader in the industry, utilizing over 40 years of collective experience in clinical research and applied translational medicine. Our key focus is to provide clients with rapid, reliable data that allows for informed go/no-go decisions during the drug development process.

In-depth knowledge, innovative methodology, and a global network of expert professionals form the backbone of Celerion’s operations. We conduct first-in-human trials, proof-of-concept studies, and provide comprehensive bioanalytical support, which helps ensure that all projects are managed efficiently across various therapeutic areas. The company boasts an extensive range of clinical facilities worldwide and is committed to maintaining the highest ethical standards in research. By integrating the latest technologies into our clinical trials, we enhance the quality and speed of data delivery to our clients, ensuring they can bring life-changing therapies to patients in need effectively. Celerion’s mission is not just about conducting studies; it is about advancing health innovation through collaboration and scientific excellence, thereby making a meaningful difference in the lives of individuals around the globe.